Top conditions
Top treatments
Parent organization
This site is a part of Eximia Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study particip...
Clinical trials
Research sites
Resources
Legal